Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Year in Review
  • Published:

Predialysis chronic kidney disease in 2010

Novel targets for slowing CKD progression

Nature Reviews Nephrology volume 7, pages 65–66 (2011)Cite this article

Several 2010 trials have provided novel information on how best to manage patients with predialysis chronic kidney disease (CKD). Armed with these new findings, nephrologists can find new means of slowing CKD progression by targeting blood-pressure control, acidosis and serum uric acid levels.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Appel, L. et al. Intensive blood-pressure control in hypertensive chronic kidney disease. N. Engl. J. Med. 363, 918–929 (2010).

    Article  CAS  Google Scholar 

  2. Menon, V. et al. Serum bicarbonate and long-term outcomes in CKD. Am. J. Kidney Dis. 56, 907–914 (2010).

    Article  CAS  Google Scholar 

  3. de Brito-Ashurst, I., Varagunam, M., Raftery, M. & Yaqoob, M. M. Bicarbonate supplementation slows progression of CKD and improves nutritional status. J. Am. Soc. Nephrol. 20, 2075–2084 (2009).

    Article  CAS  Google Scholar 

  4. Bellomo, G. et al. Association of uric acid with change in kidney function in healthy normotensive individuals. Am. J. Kidney Dis. 56, 264–272 (2010).

    Article  CAS  Google Scholar 

  5. Wen, C. P. et al. Is high serum uric acid a risk marker or a target for treatment? Examination of its independent effect in a large cohort with low cardiovascular risk. Am. J. Kidney Dis. 56, 273–288 (2010).

    Article  CAS  Google Scholar 

  6. Madero, M. et al. Uric acid and long-term outcomes in CKD. Am. J. Kidney Dis. 53, 796–803 (2009).

    Article  CAS  Google Scholar 

  7. Goicoechea, M. et al. Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin. J. Am. Soc. Nephrol. 5, 1388–1393 (2010).

    Article  CAS  Google Scholar 

  8. Ridker, P. M., MacFadyen, J., Cressman, M. & Glynn, R. J. Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention—an Intervention Trial Evaluating Rosuvastatin) trial. J. Am. Coll. Cardiol. 55, 1266–1273 (2010).

    Article  CAS  Google Scholar 

  9. Carrero, J. J. & Stenvinkel, P. Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal. Clin. J. Am. Soc. Nephrol. 4 (Suppl. 1), S49–S55 (2009).

    Article  CAS  Google Scholar 

  10. Baigent, C. et al. The results of the Study of Heart and Renal Protection; late-breaking clinical trial. Presented at Renal Week 2010: American Society of Nephrology 43rd Annual Meeting.

Download references

Author information

Authors and Affiliations

  1. Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska University Hospital at Huddinge, Karolinska Institutet, Stockholm, SE 141 86, Sweden

    Juan Jesús Carrero & Peter Stenvinkel

Authors
  1. Juan Jesús Carrero
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter Stenvinkel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter Stenvinkel.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carrero, J., Stenvinkel, P. Novel targets for slowing CKD progression. Nat Rev Nephrol 7, 65–66 (2011). https://doi.org/10.1038/nrneph.2010.177

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2010.177

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing